Vaccine Technologies and Global Markets
Global sales of human and animal vaccines reached approximately $25.2 billion in 2009. The market is expected to rise at a compound annual growth rate (CAGR) of 17.9% to reach $64.2 billion by 2015.
The global market for human vaccines in 2008 was $18.7 billion and, with a continuing increase in the global market, reached $21.2 billion in 2009. This market is expected to rise at a compound annual growth rate (CAGR) of 19.6% to reach $58.6 billion by the end of 2015.
The animal vaccines market grew from approximately $3.8 billion in 2008 to about $4.0 billion in 2009, an increase of about 5.9%. This market is expected to increase at a 5.7% compound annual growth rate (CAGR) between 2010 and 2015 to reach $5.6 billion in 2015.
Buy Now: Market Research
Related Reports
- Stakeholder Opinions: Vaccine antigen delivery technologies – Molecular systems to open new markets
- The Future of Global Vaccines – Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis
- H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
- Global Biometrics Technology Market (2010-2015) – Market Forecast by Products, End-User Application and Geography
- Probiotic Market- Advanced Technologies and Global Market (2009 – 2014)
- Innovations and Opportunities in Therapeutic Vaccines: Technology platforms, key players, and early pipeline candidates
- Advances in Vaccine Technology and Delivery
- Stakeholder Opinions: Vaccine administration technologies – Beyond needles
- Aeras Global TB Vaccine Foundation-Detailed Product Pipeline
- Aeras Global TB Vaccine Foundation-Deals & Alliances Report
